Open AccessThe Development of Metabolic Risk Factors After the Initiation of the Second Line Anti- Retroviral Therapy
Author(s) -
Apoorva Mittal,
Basavaprabhu Achappa,
Deepak Madi,
Mukta N Chowta,
John T Ramapuram,
Satish Rao,
Bhaskaran Unnikrishnan,
Soundarya Mahalingam
Publication year - 2013
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2013/4740.2743
Subject(s) - lipodystrophy , medicine , lipid profile , protease , cholesterol , insulin resistance , endocrinology , insulin , pharmacology , immunology , human immunodeficiency virus (hiv) , viral load , biology , antiretroviral therapy , enzyme , biochemistry
A Highly Active Anti-Retroviral Therapy (HAART) is accompanied with several metabolic effects like adipose redistribution and insulin resistance. In this study, we evaluated the association between a HAART and lipodystrophy.